Literature DB >> 22912557

Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer.

Tan-Hsia Chen1, Chi-Chou Huang, Kun-Tu Yeh, Shu-Hau Chang, Shih-Wen Chang, Wen-Wei Sung, Ya-Wen Cheng, Huei Lee.   

Abstract

AIM: To investigate the association between human papilloma virus (HPV) infection and colorectal cancer.
METHODS: Sixty-nine patients with pathologically confirmed primary colorectal cancer including 6 stage I, 24 stage II, 21 stage III, and 18 stage IV patients were enrolled in this study to investigate whether HPV 16 could be involved in colorectal tumorigenesis. Nested-polymerase chain reaction (nested-PCR) was used to detect HPV16 DNA in colorectal tumor tissues and further confirmed by in situ hybridization (ISH). In addition, immunohistochemistry analysis was performed to examine the E6 oncoprotein in colorectal tumors. To verify whether E6 could inactivate the p53 transcriptional function, the levels of p21 and Mdm2 mRNA expression were evaluated by real-time reverse transcription (RT)-PCR.
RESULTS: Of the 69 colorectal tumors, HPV16 DNA was detected in 11 (16%) by nested-PCR, and HPV16 DNA was present in 8 of the 11 (73%) tumors which was confirmed by ISH. The presence of HPV16 DNA in colorectal tumors was not associated with patients' clinical parameters including age, gender, smoking status, tumor site; however, HPV16 infection was more common in stage I patients than in late-stages patients (II, III and IV). We next asked whether HPV16 infection could be linked with colorectal cancer development. Immunohistochemical data indicated that 8 of the 11 HPV16 DNA-positive tumors had E6 oncoprotein expression. Moreover, we also observed that the adjacent normal tissues including endothelial cells, lymphocytes, fibroblasts, and gland cells in E6-positive tumors had E6 oncoprotein expression. In addition, 3 of the 4 (75%) E6-positive tumors carrying p53 wild-type had negative immunostaining, but one tumor had less p53 immunostaining. We further examined whether E6-positive and/or p53 mutated tumors reduce p53 transcriptional activity. Real-time RT-PCR analysis indicated that p21 and mdm2 mRNA expression levels in E6/p53-wildtype tumors were significantly lower than in their adjacent normal tissues; as expected, E6-positive/p53-mutated tumors had lower p21 and mdm2 mRNA expression levels compared with their adjacent normal tissues. These results clearly indicate that the E6 oncoprotein expressed in p53 wildtype tumors may reduce p21 and mdm2 expression via p53 inactivation.
CONCLUSION: These results suggest that HPV16 infection may be involved in a subset of colorectal cancer, and we suggest that the transmission of HPV to the colon and rectum might occur through peripheral blood lymphocytes.

Entities:  

Keywords:  Blood lymphocytes; Colorectal cancer; Human papilloma virus; p21; p53

Mesh:

Substances:

Year:  2012        PMID: 22912557      PMCID: PMC3420003          DOI: 10.3748/wjg.v18.i30.4051

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

Review 1.  Viruses in human cancers.

Authors:  H zur Hausen
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

2.  The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women.

Authors:  Y W Cheng; H L Chiou; G T Sheu; L L Hsieh; J T Chen; C Y Chen; J M Su; H Lee
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

3.  The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan.

Authors:  Hui-Ling Chiou; Ming-Fang Wu; Yu-Ching Liaw; Ya-Wen Cheng; Ruey-Hong Wong; Chin-Yi Chen; Huei Lee
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

4.  Papillomavirus capsid binding and uptake by cells from different tissues and species.

Authors:  M Müller; L Gissmann; R J Cristiano; X Y Sun; I H Frazer; A B Jenson; A Alonso; H Zentgraf; J Zhou
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

5.  Limited evidence of human papillomavirus in [corrected] breast tissue using molecular in situ methods.

Authors:  Kimberly Baltzell; Gertrude C Buehring; Savitri Krishnamurthy; Henry Kuerer; Hua Min Shen; Jennette D Sison
Journal:  Cancer       Date:  2011-08-05       Impact factor: 6.860

Review 6.  Human papillomavirus (HPV) in head and neck cancer.

Authors:  Stina Syrjänen
Journal:  J Clin Virol       Date:  2005-03       Impact factor: 3.168

Review 7.  High-risk mucosal human papillomavirus infections during infancy & childhood.

Authors:  John Cason; Christine A Mant
Journal:  J Clin Virol       Date:  2005-03       Impact factor: 3.168

8.  Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students.

Authors:  Rachel L Winer; Shu-Kuang Lee; James P Hughes; Diane E Adam; Nancy B Kiviat; Laura A Koutsky
Journal:  Am J Epidemiol       Date:  2003-02-01       Impact factor: 4.897

9.  Detection of human papillomavirus DNA in colorectal carcinomas by polymerase chain reaction.

Authors:  J Y Cheng; L F Sheu; C L Meng; W H Lee; J C Lin
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

10.  Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission.

Authors:  Elaine M Smith; Justine M Ritchie; Jerome Yankowitz; Sandhya Swarnavel; Donghong Wang; Thomas H Haugen; Lubomir P Turek
Journal:  Sex Transm Dis       Date:  2004-01       Impact factor: 2.830

View more
  23 in total

Review 1.  Gastrointestinal malignancy and the microbiome.

Authors:  Maria T Abreu; Richard M Peek
Journal:  Gastroenterology       Date:  2014-01-07       Impact factor: 22.682

Review 2.  Colorectal carcinogenesis--update and perspectives.

Authors:  Hans Raskov; Hans-Christian Pommergaard; Jakob Burcharth; Jacob Rosenberg
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

3.  Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.

Authors:  Fang Li; Jinquan Cui
Journal:  Med Oncol       Date:  2015-06-12       Impact factor: 3.064

4.  Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker P16 (INK4a) are useful prognostic markers in uterine cervical carcinomas in Qassim Region--Saudi Arabia.

Authors:  O M Omran; M AlSheeha
Journal:  Pathol Oncol Res       Date:  2014-06-13       Impact factor: 3.201

5.  Human papillomavirus does not have a causal role in colorectal carcinogenesis.

Authors:  Laura Lorenzon; Francesca Mazzetta; Emanuela Pilozzi; Giordana Uggeri; Maria Rosaria Torrisi; Mario Ferri; Vincenzo Ziparo; Deborah French
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

6.  Cancer incidence in a Nationwide HIV/AIDS patient cohort in Taiwan in 1998-2009.

Authors:  Marcelo Chen; Ian Jen; Yi-Hsien Chen; Ming-Wei Lin; Kishor Bhatia; Gerald B Sharp; Matthew G Law; Yi-Ming Arthur Chen
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

Review 7.  Human papillomavirus and colorectal cancer.

Authors:  Marina K Ibragimova; Matvey M Tsyganov; Nicolay V Litviakov
Journal:  Med Oncol       Date:  2018-09-05       Impact factor: 3.064

8.  Human papillomavirus infection correlates with inflammatory Stat3 signaling activity and IL-17 level in patients with colorectal cancer.

Authors:  Yi Xin Li; Lei Zhang; Dilixia Simayi; Nan Zhang; Lin Tao; Lan Yang; Jin Zhao; Yun Zhao Chen; Feng Li; Wen Jie Zhang
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

9.  Significance of infectious agents in colorectal cancer development.

Authors:  Vlado Antonic; Alexander Stojadinovic; Kent E Kester; Peter J Weina; Björn Ldm Brücher; Mladjan Protic; Itzhak Avital; Mina Izadjoo
Journal:  J Cancer       Date:  2013-03-15       Impact factor: 4.207

10.  Viral expression associated with gastrointestinal adenocarcinomas in TCGA high-throughput sequencing data.

Authors:  Daria Salyakina; Nicholas F Tsinoremas
Journal:  Hum Genomics       Date:  2013-11-27       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.